The global market for Rapamycin API was valued at US$ 714 million in the year 2024 and is projected to reach a revised size of US$ 921 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Rapamycin API (Active Pharmaceutical Ingredient) is the raw, biologically active substance used in the formulation of pharmaceutical products containing Rapamycin (Sirolimus). It is manufactured under strict Good Manufacturing Practices (GMP) to ensure purity, potency, and safety for medical use.
North American market for Rapamycin API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rapamycin API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Rapamycin API include Dr. Reddy’s Laboratories, Biocon, Aurisco Pharmaceutical, Macheng Jinxin Biotech, MP Biomedicals, TCI America, Enzo Life Sciences, Conformity Chemical, Kede Chemical, Hubei Xinkang Pharmaceutical Chemical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rapamycin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapamycin API.
The Rapamycin API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rapamycin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapamycin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy’s Laboratories
Biocon
Aurisco Pharmaceutical
Macheng Jinxin Biotech
MP Biomedicals
TCI America
Enzo Life Sciences
Conformity Chemical
Kede Chemical
Hubei Xinkang Pharmaceutical Chemical
Cfm Oskar Tropitzsch
OCTAGONCHEM
Hangzhou Longshine Bio-Tech
ChemWerth Inc
by Type
More than 99%
Less than 99%
by Application
Tablets
Capsules
Oral Solution
Injection
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rapamycin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Rapamycin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Rapamycin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Rapamycin API Market Overview
1.1 Product Definition
1.2 Rapamycin API by Type
1.2.1 Global Rapamycin API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 More than 99%
1.2.3 Less than 99%
1.3 Rapamycin API by Application
1.3.1 Global Rapamycin API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Oral Solution
1.3.5 Injection
1.4 Global Market Growth Prospects
1.4.1 Global Rapamycin API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Rapamycin API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Rapamycin API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Rapamycin API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Rapamycin API Production Market Share by Manufacturers (2020-2025)
2.2 Global Rapamycin API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Rapamycin API, Industry Ranking, 2023 VS 2024
2.4 Global Rapamycin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Rapamycin API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Rapamycin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Rapamycin API, Product Offered and Application
2.8 Global Key Manufacturers of Rapamycin API, Date of Enter into This Industry
2.9 Rapamycin API Market Competitive Situation and Trends
2.9.1 Rapamycin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Rapamycin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Rapamycin API Production by Region
3.1 Global Rapamycin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Rapamycin API Production Value by Region (2020-2031)
3.2.1 Global Rapamycin API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Rapamycin API by Region (2026-2031)
3.3 Global Rapamycin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Rapamycin API Production Volume by Region (2020-2031)
3.4.1 Global Rapamycin API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Rapamycin API by Region (2026-2031)
3.5 Global Rapamycin API Market Price Analysis by Region (2020-2025)
3.6 Global Rapamycin API Production and Value, Year-over-Year Growth
3.6.1 North America Rapamycin API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Rapamycin API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Rapamycin API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Rapamycin API Production Value Estimates and Forecasts (2020-2031)
4 Rapamycin API Consumption by Region
4.1 Global Rapamycin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Rapamycin API Consumption by Region (2020-2031)
4.2.1 Global Rapamycin API Consumption by Region (2020-2025)
4.2.2 Global Rapamycin API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Rapamycin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Rapamycin API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Rapamycin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Rapamycin API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Rapamycin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Rapamycin API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Rapamycin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Rapamycin API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Rapamycin API Production by Type (2020-2031)
5.1.1 Global Rapamycin API Production by Type (2020-2025)
5.1.2 Global Rapamycin API Production by Type (2026-2031)
5.1.3 Global Rapamycin API Production Market Share by Type (2020-2031)
5.2 Global Rapamycin API Production Value by Type (2020-2031)
5.2.1 Global Rapamycin API Production Value by Type (2020-2025)
5.2.2 Global Rapamycin API Production Value by Type (2026-2031)
5.2.3 Global Rapamycin API Production Value Market Share by Type (2020-2031)
5.3 Global Rapamycin API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Rapamycin API Production by Application (2020-2031)
6.1.1 Global Rapamycin API Production by Application (2020-2025)
6.1.2 Global Rapamycin API Production by Application (2026-2031)
6.1.3 Global Rapamycin API Production Market Share by Application (2020-2031)
6.2 Global Rapamycin API Production Value by Application (2020-2031)
6.2.1 Global Rapamycin API Production Value by Application (2020-2025)
6.2.2 Global Rapamycin API Production Value by Application (2026-2031)
6.2.3 Global Rapamycin API Production Value Market Share by Application (2020-2031)
6.3 Global Rapamycin API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Dr. Reddy’s Laboratories
7.1.1 Dr. Reddy’s Laboratories Rapamycin API Company Information
7.1.2 Dr. Reddy’s Laboratories Rapamycin API Product Portfolio
7.1.3 Dr. Reddy’s Laboratories Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Dr. Reddy’s Laboratories Main Business and Markets Served
7.1.5 Dr. Reddy’s Laboratories Recent Developments/Updates
7.2 Biocon
7.2.1 Biocon Rapamycin API Company Information
7.2.2 Biocon Rapamycin API Product Portfolio
7.2.3 Biocon Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Biocon Main Business and Markets Served
7.2.5 Biocon Recent Developments/Updates
7.3 Aurisco Pharmaceutical
7.3.1 Aurisco Pharmaceutical Rapamycin API Company Information
7.3.2 Aurisco Pharmaceutical Rapamycin API Product Portfolio
7.3.3 Aurisco Pharmaceutical Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Aurisco Pharmaceutical Main Business and Markets Served
7.3.5 Aurisco Pharmaceutical Recent Developments/Updates
7.4 Macheng Jinxin Biotech
7.4.1 Macheng Jinxin Biotech Rapamycin API Company Information
7.4.2 Macheng Jinxin Biotech Rapamycin API Product Portfolio
7.4.3 Macheng Jinxin Biotech Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Macheng Jinxin Biotech Main Business and Markets Served
7.4.5 Macheng Jinxin Biotech Recent Developments/Updates
7.5 MP Biomedicals
7.5.1 MP Biomedicals Rapamycin API Company Information
7.5.2 MP Biomedicals Rapamycin API Product Portfolio
7.5.3 MP Biomedicals Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 MP Biomedicals Main Business and Markets Served
7.5.5 MP Biomedicals Recent Developments/Updates
7.6 TCI America
7.6.1 TCI America Rapamycin API Company Information
7.6.2 TCI America Rapamycin API Product Portfolio
7.6.3 TCI America Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 TCI America Main Business and Markets Served
7.6.5 TCI America Recent Developments/Updates
7.7 Enzo Life Sciences
7.7.1 Enzo Life Sciences Rapamycin API Company Information
7.7.2 Enzo Life Sciences Rapamycin API Product Portfolio
7.7.3 Enzo Life Sciences Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Enzo Life Sciences Main Business and Markets Served
7.7.5 Enzo Life Sciences Recent Developments/Updates
7.8 Conformity Chemical
7.8.1 Conformity Chemical Rapamycin API Company Information
7.8.2 Conformity Chemical Rapamycin API Product Portfolio
7.8.3 Conformity Chemical Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Conformity Chemical Main Business and Markets Served
7.8.5 Conformity Chemical Recent Developments/Updates
7.9 Kede Chemical
7.9.1 Kede Chemical Rapamycin API Company Information
7.9.2 Kede Chemical Rapamycin API Product Portfolio
7.9.3 Kede Chemical Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Kede Chemical Main Business and Markets Served
7.9.5 Kede Chemical Recent Developments/Updates
7.10 Hubei Xinkang Pharmaceutical Chemical
7.10.1 Hubei Xinkang Pharmaceutical Chemical Rapamycin API Company Information
7.10.2 Hubei Xinkang Pharmaceutical Chemical Rapamycin API Product Portfolio
7.10.3 Hubei Xinkang Pharmaceutical Chemical Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Hubei Xinkang Pharmaceutical Chemical Main Business and Markets Served
7.10.5 Hubei Xinkang Pharmaceutical Chemical Recent Developments/Updates
7.11 Cfm Oskar Tropitzsch
7.11.1 Cfm Oskar Tropitzsch Rapamycin API Company Information
7.11.2 Cfm Oskar Tropitzsch Rapamycin API Product Portfolio
7.11.3 Cfm Oskar Tropitzsch Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Cfm Oskar Tropitzsch Main Business and Markets Served
7.11.5 Cfm Oskar Tropitzsch Recent Developments/Updates
7.12 OCTAGONCHEM
7.12.1 OCTAGONCHEM Rapamycin API Company Information
7.12.2 OCTAGONCHEM Rapamycin API Product Portfolio
7.12.3 OCTAGONCHEM Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 OCTAGONCHEM Main Business and Markets Served
7.12.5 OCTAGONCHEM Recent Developments/Updates
7.13 Hangzhou Longshine Bio-Tech
7.13.1 Hangzhou Longshine Bio-Tech Rapamycin API Company Information
7.13.2 Hangzhou Longshine Bio-Tech Rapamycin API Product Portfolio
7.13.3 Hangzhou Longshine Bio-Tech Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Hangzhou Longshine Bio-Tech Main Business and Markets Served
7.13.5 Hangzhou Longshine Bio-Tech Recent Developments/Updates
7.14 ChemWerth Inc
7.14.1 ChemWerth Inc Rapamycin API Company Information
7.14.2 ChemWerth Inc Rapamycin API Product Portfolio
7.14.3 ChemWerth Inc Rapamycin API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 ChemWerth Inc Main Business and Markets Served
7.14.5 ChemWerth Inc Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Rapamycin API Industry Chain Analysis
8.2 Rapamycin API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Rapamycin API Production Mode & Process Analysis
8.4 Rapamycin API Sales and Marketing
8.4.1 Rapamycin API Sales Channels
8.4.2 Rapamycin API Distributors
8.5 Rapamycin API Customer Analysis
9 Rapamycin API Market Dynamics
9.1 Rapamycin API Industry Trends
9.2 Rapamycin API Market Drivers
9.3 Rapamycin API Market Challenges
9.4 Rapamycin API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Dr. Reddy’s Laboratories
Biocon
Aurisco Pharmaceutical
Macheng Jinxin Biotech
MP Biomedicals
TCI America
Enzo Life Sciences
Conformity Chemical
Kede Chemical
Hubei Xinkang Pharmaceutical Chemical
Cfm Oskar Tropitzsch
OCTAGONCHEM
Hangzhou Longshine Bio-Tech
ChemWerth Inc
Ìý
Ìý
*If Applicable.
